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ABSTRACT OF THESIS 
 
 
 
 
A COMPARISON BETWEEN MASTICATORY MUSCLE AND 
TEMPOROMANDIBULAR JOINT PAIN PATIENTS WITH REGARD TO THE 
PREVALENCE AND IMPACT OF POST-TRAUMATIC STRESS DISORDER 
SYMPTOMS. 
 
 The purpose of this study was to evaluate masticatory muscle (MM) and 
temporomandibular joint (TMJ) pain patients regarding the prevalence of Post-
traumatic Stress Disorder (PTSD) symptoms, and evaluate the level of 
psychological dysfunction and its relationship to PTSD symptoms in these 
patients. This study included 445 adult patients (male = 42, female = 403). 
Psychological questionnaires included the Symptom Check List-90-Revised 
(SCL-90-R), the Multidimensional Pain Inventory, the Pittsburgh Sleep Quality 
Index and the PTSD Check List Civilian. The total sample of patients was divided 
into two major groups: The MM group (n=242) and TMJ group (n=203). Each 
group was divided into three subgroups according to the presence of a stressor 
and severity of PTSD symptoms. Thirty six patients (14.9%) in the MM group and 
20 patients (9.9%) in the TMJ group presented symptomatology of PTSD. MM 
and TMJ pain patients in the “positive PTSD” subgroups scored higher on all 
scales of the SCL-90-R (p = .000) than the other two subgroups and reached 
levels of distress that were indicative of psychological dysfunction. MM and TMJ 
pain patients in the “positive PTSD” subgroups were more often classified as 
dysfunctional than as adaptive copers and presented with more sleep 
disturbances than patients in the “no stressor” and “negative PTSD” subgroups. 
A somewhat elevated prevalence rate for PTSD symptomatology was found in 
the MM than in the TMJ group. Significant levels of psychological dysfunction 
appear limited to temporomandibular disorder patients with symptoms of PTSD. 
 
KEYWORDS: Prevalence, TMD, PTSD, psychological dysfunction, sleep 
disturbances.  
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Chapter 1. Introduction 
Post-traumatic Stress Disorder (PTSD) is defined as a type of anxiety 
disorder that can develop following an individual’s exposure to an event 
perceived to be threatening or traumatic according to the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-IV)1, see Table 1. As a 
consequence of such exposure, a person may develop a recurring pattern of 
symptoms. These symptoms include persistent re-experiencing of the traumatic 
event, nightmares, recurrent and intrusive recollections, avoidance of the 
situations associated with the traumatic event, sleeplessness, and hypervigilance 
that must be present for more than one month 1. Post-traumatic Stress Disorder 
can be classified as acute, when symptoms are present between one and three 
months or chronic when symptoms last for three months or more. Finally, PTSD 
can be classified as delayed onset when at least six months have passed 
between the traumatic event and the onset of the disorder. Post-traumatic Stress 
Disorder may coexist with others psychological disorders 2, 3 and also with 
chronic pain conditions such as fibromyalgia 4, 5, headache 6 and 
temporomandibular disorder (TMD) 7, 8.  
Temporomandibular disorders (TMDs) comprise a number of clinical 
problems involving the masticatory muscles and/or the temporomandibular joint 
(TMJ) joint 9 that also have been associated with elevated levels of depression 
and anxiety 10, 11, 12, 13. Studies comparing the two most common categories of 
TMD, masticatory muscle (MM) pain and TMJ/intracapsular pain, revealed that 
MM pain patients are more psychologically distressed than TMJ pain patients 14, 
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15, 16, 17. In general, psychological distress has been linked to increased pain 
level in a number of investigations 4, 12, 18, 19, 20.  
Anxiety disorders, such as PTSD, may have the potential to magnify the 
subjective perception of pain 21. Several studies have examined the relationship 
between PTSD and chronic pain 5,18, 22, 23, 24, 25,. For instance, Sherman et al 
found in a sample of fibromyalgia patients that pain level, disability and affective 
distress was greater in those patients reporting PTSD symptoms than those who 
did not report such symptoms 4. There are a small number of investigations 
reporting the comorbidity of PTSD and TMD 7, 8, 19. A recent investigation in 
chronic orofacial pain patients revealed that the patients who reported symptoms 
of PTSD were more psychologically distressed and more prone to be classified 
with a dysfunctional profile than patients who did not report symptoms of PTSD 
19. An additional finding of this investigation was that clinically significant levels of 
psychological distress are strongly linked with PTSD. It also has been reported 
that traumatic experiences and more PTSD symptoms were observed in MM 
pain patients compared to TMJ pain patents 17, 26. Apparently, the coexistence 
and interaction of chronic pain/ TMD and PTSD is related to an increased 
psychological distress, elevated levels of pain and greater disability. Such 
characteristics may influence a patient’s adaptability to disease and treatment 
outcomes. Consequently, the successful management of patients with chronic 
pain/TMD requires assessment of comorbid psychological conditions. Thus, 
screening for PTSD should be included as part of a TMD patient’s evaluation.  
 
Copyright © 2005, Elizangela Bertoli 
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Table1. Diagnostic Criteria for PTSD, DSM-IV1. 
A The person has been exposed to a traumatic event in which both of the following were present : 
1 
 
2 
The person experienced, witnessed, or was confronted with an event or events that involved actual or 
threatened death or serious injury, or a threat to the physical integrity of self or others 
The person’s response to the event involves intense fear, helplessness or horror  
B The traumatic event is persistently re-experienced in one (or more) of the following ways: 
1 
2 
3 
 
 
4 
 
5 
Recurrent and  intrusive distressing recollections of the event, including images, thoughts, or perceptions 
Recurrent distressing dreams of the event 
Acting or feeling as if the traumatic event were recurring (includes a sense of reliving the experience, 
illusions, hallucinations, and dissociative flashback episodes, including those that occur on awakening or 
when intoxicated) 
Intense psychological distress at exposure to internal or external cues that symbolize or resemble an 
aspect of the traumatic event 
Psychological reactivity on exposure to internal or external cues that symbolize or resemble an aspect of 
the traumatic event 
C Persistent avoidance of stimuli associated with the trauma and numbing of general responsiveness (not 
present before the trauma), as indicated by three (or more) of the following: 
1 
2 
3 
4 
5 
6 
7 
Efforts to avoid thoughts, feeling, or conversations associated with the trauma 
Efforts to avoid activities, places, or people that arose recollections of the trauma 
Inability to recall an important aspect of the trauma 
Markedly diminished interest or participation in significant activities 
Feelings of detachment or estrangement from others  
Restricted range of affect (e.g., unable to have loving feelings) 
Sense of foreshortened future (e.g., does not expect to have a career, marriage, children, or normal life 
span) 
D Persistent symptoms of increased arousal (not present before the trauma), as indicated by two (or more) 
of the following: 
1 
2 
3 
4 
5 
Difficulty falling or staying asleep 
Irritability or outbursts of anger  
Difficulty concentrating  
Hypervigilance  
Exaggerated startle response 
E Duration of the disturbance (symptoms in criteria B,C, and D) is more than one month 
F  
 
The disturbance causes clinically significant distress or impairment in social, occupational or other 
important areas of functioning 
PTSD: Post-traumatic Stress Disorder. 
DSM-IV: Diagnostic and Statistical Manual of Mental Disorders-IV. 
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Chapter 2. Purpose of the Study 
 
The aim of this investigation was to evaluate differences between MM pain 
patients and TMJ pain patients who sought treatment at the Orofacial Pain 
Center in the University of Kentucky with regard to the prevalence of PTSD 
symptoms. A second aim of this study was to analyze the level of psychological 
dysfunction and its relationship in regard to the presence and impact of PTSD 
symptoms in MM pain patients and TMJ pain patients. We hypothesized that the 
prevalence of PTSD symptoms would be higher in MM pain patients than in TMJ 
pain patients. In addition, given the complicated nature of PTSD symptoms we 
hypothesized that the presence of this symptomatology would influence the level 
of psychological dysfunction in MM and TMJ pain patients in several domains.  
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Chapter 3. Review of the Literature 
 
 
3.1. Temporomandibular Disorders  
3.1.2. Temporomandibular Disorders and Psychological Distress 
 
According to the Research Diagnostic Criteria 27, TMDs are divided in two 
main categories: MM pain and TMJ (intracapsular) pain. Regarding etiology, 
TMD is often considered complex and multifactorial in nature. Factors such as 
trauma, constant deep pain input, orthopedic instability, parafunctional activities, 
systemic factors and emotional stressors have been implicated in the etiology of 
TMD 28. Dworkin and LeResche 27 pointed out the importance of adding to the 
Axis I which, comprises the physical conditions responsible for the etiology of 
pain, a psychological aspect, the so called Axis II in the diagnosis of TMD. Axis II 
involves the psychological condition and its effects in producing and/or 
influencing the whole pain experience. 
Several lines of evidence have linked TMD and psychological distress 11, 
29, 30. For instance, elevated levels of depression and anxiety are common 
findings in TMD patients compared with healthy controls 10, 16, 31, 32, 33, 34. 
Psychological distress is more often associated with MM pain patients than TMJ 
pain patients 14, 15, 17. In fact, MM pain patients report elevated levels of 
depression, pain disability and exposure to major life stressors when compared 
to intracapsular pain patients 20, 35. Major life stressors in turn have been 
associated with high levels of pain, affective distress and disability in TMD 
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patients 20. Lampe et al 36 noted that stressful life events such as childhood 
abuse and depression experienced by chronic pain patients had a significant 
impact on the occurrence of the chronic pain condition. In regard to TMD, Curran 
et al 12 reported that 68.9% of orofacial pain patients reported a history of 
physical and sexual abuse in an anonymous survey. The history of abuse was 
significantly correlated to depression, psychological distress and greater pain 
severity. There is also evidence suggesting that TMD patients suffer stressful life 
events prior to the onset of their symptomatology 20, 37, 38. Overall, traumatic life 
experiences seem to interfere with the well-being of patients and may have a 
substantial link to the occurrence of TMDs.  
The activity of the sympathetic portion of the autonomic nervous system is  
increased by emotional stress. This is the so called stress response or “fight or 
flight” response which is characterized by an increase in the arterial blood 
pressure, blood flow to muscles, muscle activity and mental activity 39. Although, 
this increased autonomic activity is normal for acute stressors, major life events 
and/or persistent chronic stressors may also have long term consequences for 
an individual depending on how s/he perceives a situation and her/his general 
state of physical health 40. McEwen in 1998 described these consequences as an 
increased activity of the “allostatic systems” (autonomic nervous, cardiovascular, 
metabolic and immune systems and hypothalamic-pituitary-adrenal (HPA) axis), 
the allostatic load theory, that may result in chronic overactivity of these systems 
40. It is known, for example, that chronic emotional stress may produce pain and 
increase its severity by precipitating and increasing activity in the central nervous 
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and musculoskeletal systems 41. In addition, it has been demonstrated that there 
is increased cardiovascular activity and altered breathing rate in chronic TMD 
patients compared to normal controls 34.  
An additional response to a stressor is the activation of the HPA-axis in 
response to stimulation of the sympathetic nervous system. This activation 
releases catecholamines that stimulate the secretion of corticotrophin-releasing 
factor (CRF) from the hypothalamus. Corticotrophin-releasing factor then induces 
the secretion of adrenocorticotropin hormone (ACTH), from the pituitary gland. It, 
in turn, mediates the release of cortisol from the adrenal cortex. This sequence of 
events that culminates in an increase of cortisol levels is a normal and ordinary 
response to any type of acute stress (physical or mental). The acute increase in 
cortisol is of significant benefit because glucocorticoids cause rapid mobilization 
of aminoacids and fats making them available for energy and for synthesis of 
other compounds 39. However, chronic activation of the HPA-axis can cause 
pathophysiologic consequences such as down-regulation of the hippocampal 
glucocorticoid receptors and toxicity to hippocampal neurons leading to cognitive 
impairment that can alter memory 42, 43, 44.  
Dysregulation of the HPA-axis has been related to several psychological 
disorders as well as to stress-related bodily disorders. In fact, hyperactivity of the 
HPA-axis that produces high levels of cortisol is an ordinary finding in affective 
disorders such as depression 13, 45, 46. In contrast to affective disorders, stress-
related bodily disorders like chronic fatigue syndrome and fibromyalgia are 
characterized by hypocortisolism 46, 47, 48, 49. In addition, hypocortisolism has 
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been found in other somatoform disorders such as rheumatoid arthritis and 
asthma 50. Indeed, hyporesponsiveness of the HPA-axis is associated with 
increased inflammatory cytokines 51 and its consequences have also been 
reported in animal studies 52. The animals in these studies were very susceptible 
to autoimmune and inflammatory disturbances 52.  
It also appears that dysregulation of the HPA-axis plays an important role 
in chronic pain and may actually predispose vulnerability for the development of 
chronic pain 50. With TMDs, however, inconsistent findings have been reported in 
the neuroendocrinologic investigations. For instance, Jones et al in 1997 
analyzing TMD patients and a control group noted that the TMD group was 
heterogeneous in regard to the levels of cortisol released in response to stress. 
The authors found TMD patients with increased cortisol levels and TMD patients 
whose cortisol levels were not different from healthy controls 53. Other 
investigation revealed hypercortisolism in a group of 15 women with TMD 
patients compared to a control group 54. Even though the patients were initially 
screened for psychological disorders, three subjects presented with symptoms of 
major depression. Interestingly, the methodology included the assessment of 
cortisol by plasma levels. It has been speculated that cortisol levels may fluctuate 
as a result of transient stressors in the environment including the actual stress of 
venipuncture or anticipatory anxiety associated with venipuncture 55. Overall the 
findings suggest that chronic pain disorders including TMD potentially are related 
to dysregulation of the HPA-axis.  
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3.1.3. Temporomandibular Disorders and Sleep Disturbance  
 
From the available literature, it is currently unknown whether chronic pain 
conditions produce a sleep disturbance or whether a sleep disturbance is 
significant in the initiation of the chronic pain condition itself. According to 
Okeson, sleep disturbances may be a systemic perpetuating factor that can 
cause the progression of an acute muscle pain to a chronic pain condition 28. The 
available literature reveals a strong relationship between sleep problems and 
chronic pain. Poor sleep quality has been linked to chronic pain conditions 56, 57, 
58, 59. The deeper stages of sleep are important to restore function of the body 
systems such as the metabolic process. In fact, Moldofsky and Scarisbrick in 
1976 noted that stage-four deprivation led to musculoskeletal symptoms such as 
muscle tenderness and stiffness in healthy subjects, but such symptoms were 
not observed following disruption of the rapid eye-movement (REM) sleep 60. It 
appears that deprivation of the deeper stages of sleep may result in muscle pain 
because of the inability of an individual to repair damaged tissues. Patients with 
TMD frequently report sleep disturbance 61, 62, 63. In regard to the two categories 
of TMD, patients in the MM pain category report more sleep disturbances 
compared to patients in the TMJ pain category 17, 64. In addition, in TMD patients 
the sleep disturbance is related to elevated levels of pain severity and 
psychological distress 16, 30.  
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3.1.4. Summary 
 
From the aforementioned review it is apparent that there is a positive 
relationship between TMD and emotional stressors. This relationship may disturb 
the well-being of the patient and may impact her/his ability to cope with the 
illness. Sleep disturbances often coexist with TMD and may be considered a 
contributing factor that may play an important role in the individual’s recovery. 
Although, inconsistent findings of the neuroendocrinologic investigations have 
been reported in the literature, it seems that like in many other pain conditions, 
TMD is associated with dysregulation of the HPA-axis.   
 
3.2. Post-traumatic Stress Disorder (PTSD) 
 
Symptoms of PTSD have been reported in victims following rape 65, 66, 
motor vehicle accident 22, 67, 68, combat veterans experiences 69, medical 
conditions 70, 71 terrorist attacks 72, 73 and natural disasters 74. Based on 
community studies, the lifetime prevalence of PTSD ranges from 1% to 14% 1. 
Reports of at-risk individuals (e.g. combat veterans, survivors of natural 
disasters, terrorist attacks or criminal violence) revealed prevalence rates raging 
from 3% to 58% 1, 72, 75, 76.  
Considering chronic pain patients, several lines of evidence suggest a 
high prevalence of PTSD symptoms in such patients 4, 5, 18, 24, 77. In addition, 
PTSD co-occurs with other psychiatric diagnosis such as mood, anxiety and 
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substance abuse disorders. In fact, one study showed that approximately 80% of 
PTSD patients met criteria for at least one other psychiatric disorder 2. 
Depression is the most widely investigated comorbid disorder 3. For example, 
Hickling et al in 1992 analyzing headache patients who were victims of motor 
vehicle accident meeting diagnostic criteria for PTSD, noted that major 
depression was also present among those patients 22. The literature documenting 
a positive relationship between PTSD and substance abuse is also extensive 78, 
79, 80, 81, 82. Indeed, recent studies noted a high prevalence of cigarette smoking 
in patients with current PTSD symptoms 83, 84. The authors suggested a link 
among anxiety, PTSD, and substance abuse.  
Dysregulation of the HPA-axis is a common finding in patients reporting 
symptoms of PTSD. Although inconsistent findings have been reported in the 
literature regarding cortisol levels in PTSD patients 55, there is a trend for PTSD 
to be linked to hypocortisolism 46, 55, 85, 86. The inconsistent findings could be 
attributed to differences in the methodological assessment used in the studies. 
An additional factor that could contribute to these differences is the coexistence 
of others psychiatric disorders, such as depression, which may influence the 
findings since depression has been associated with hypercortisolism 87. It seems 
that a variation of the psychiatric symptomatology over time in PTSD patients 
may also influence cortisol levels. In addition, the time frame between the trauma 
suffered by an individual and the investigation may also affect cortisol findings 55. 
For example, there may be a difference in cortisol levels during or immediately 
after the traumatic event as compared to years after the traumatic event. It has 
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been reported that early life stressors may result in a persistent sensitization of 
the HPA-axis to stressors in adulthood 46. It also has been suggested that chronic 
PTSD is associated with increased negative feedback inhibition of cortisol, due to 
altered glucocorticoid receptor activity 88. Symptoms of PTSD such as increased 
response to stress, hypervigilance and arousal are consistent with dysregulation 
of the HPA-axis 88. 
 
3.2.1. PTSD and Sleep Disturbances 
 
Sleep disturbances are included in the symptomatology of PTSD 
according to the DSM-IV 1. They are included in the category of re-experiencing 
symptoms, for example, nightmares, and in the category of arousal that 
contributes to difficulty falling or staying asleep. Sleep disturbances and 
nightmares are part of a normal and typical response following traumatic or 
threatening trauma 89. However, for some individuals the sleep disturbance 
becomes a persistent problem. For instance, in a study of the survivors of the 
Oklahoma City bombing, 70% of the survivors reported sleep disturbance six 
months following the event 90. In addition, sleep problems were the most 
common symptom reported by survivors of natural disaster 91, war prisoners 92 
and holocaust victims 93.  
The majority of the studies reporting association between sleep 
disturbances and PTSD used subjective measures such as self-reported 
symptoms, questionnaires and medical interviews 94. Symptoms most frequently 
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reported by PTSD patients are difficulty falling or staying asleep, shorter sleep 
duration, restless sleep, daytime fatigue and nightmares 95, 96. Such sleep 
disturbances may exacerbate symptoms of PTSD. In fact, several research 
groups have reported the clinical importance of the sleep disturbance’s treatment 
in PTSD patients 97. A causal relationship between sleep disturbance and PTSD 
has not yet been reported. Harvey et al in 2003 critically assessed the evidence 
on the prevalence and treatment of sleep disturbance of patients with PTSD. 
They concluded that there is a clear association between PTSD and sleep 
problems. However, the role sleep disturbances play in the mechanism of PTSD 
is unclear 89. In other words, further studies are needed to determine whether a 
causal relationship between sleep disturbance and PTSD exists. 
 
3.2.2. Summary 
 
Following exposure to a traumatic or threatening incident an individual 
may develop symptoms of PTSD. According to the literature, PTSD has been 
linked to other psychiatric disorders such as depression and anxiety as well to 
chronic pain disorders. In addition, a positive relationship exists between PTSD 
and substance abuse and sleep disturbances. Similar to TMD, PTSD has been 
associated with dysregulation of the HPA-axis.  
 
3.3. TMD and PTSD 
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Few studies have investigated the relationship between TMD and PTSD. 
Evidence reporting a high prevalence of PTSD symptoms in orofacial pain 
patients comes from clinical data 7, 8, 19. Several lines of evidence suggest a 
higher prevalence of PTSD symptoms in the MM pain category compared to the 
TMJ pain category 17, 19, 26. Aghabeigi in 1992 found that 15% of patients with 
chronic idiopathic pain had a history of PTSD which coincided with the pain onset 
7. Sherman et al in 1998 found a PTSD prevalence rate of 23% in chronic face 
pain patients 8. In this study, patients with symptoms of PTSD reported higher 
levels of pain, greater affective distress and less control over their lives than 
patients without PTSD symptoms. Similarly, de Leeuw et al in 2005 also noted 
increased pain severity, affective distress and disability among orofacial pain 
patients with symptomatology of PTSD. A persistent finding in orofacial pain 
patients 19, headache patients 98 and neuropathic pain patients 99 is that the 
presence of PTSD symptoms may dictate elevated levels of psychological 
distress in several domains.  
The findings with regard to pain level, affective distress and disability for 
TMD patients with PTSD symptoms are in accord with previous publications in 
chronic pain. For example, Geisser et al in 1996 demonstrated that chronic pain 
patients with elevated PTSD symptoms reported increased pain and affective 
distress 18. In addition, Sherman and colleagues in 2000 evaluated a sample of 
fibromyalgia patients with and without symptomatology of PTSD noted higher 
level of pain, emotional distress, life interference and disability among patients 
reporting PTSD symptoms as compared to patients who did not report symptoms 
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of PTSD 4. A common characteristic of patients with symptoms of PTSD and 
chronic pain is that these patients present with difficulty in coping and adapting to 
their pain 4, 19. These patients are also frequently classified as dysfunctional or 
interpersonally distressed 4, 19, 100, on the MPI profile classification. The same 
tendency is observed in TMD, and seems to be more pronounced in muscle pain 
patients than in patients with primarily joint pathology 17, 64. 
Based on this review, it seems that TMD, especially the MM pain 
category, and PTSD exhibit common symptoms such as depression, anxiety, 
sleep disturbances and dysregulation of the HPA-axis. In fact an overlap of 
symptoms between chronic pain in general and PTSD has been observed in the 
literature 23. Asmundson et al in 2002 discussed two mechanisms that may 
explain the co-occurrence of these disorders, the shared vulnerability hypothesis 
and the mutual maintenance hypothesis. For the shared vulnerability hypothesis, 
an anxiety disorder may be a predisposing factor for both conditions, thereby 
increasing the susceptibility for development of both conditions 23. Considering 
the mutual maintenance mechanism that was first introduced by Sharp and 
Harvey in 2001 101, it is proposed that characteristics of either chronic pain or 
PTSD may reciprocally maintain or exacerbate the symptoms of the other 
disorder. It is postulated that for PTSD patients, chronic pain provides a 
persistent reminder of the trauma, thus in such patients an attentional bias 
towards the pain experience may exacerbate the pain condition. Furthermore, 
pain sensation may be exacerbated by high levels of anxiety. In addition, 
depression may maintain the symptomatology of PTSD and chronic pain. In 
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summary, the mutual maintenance hypothesis is based on the following 
mechanisms generated by distress: 1) attentional and reasoning biases; 2) 
anxiety sensitivity; 3) reminders of the trauma; 4) avoidance; 5) depression and 
reduced activity levels; 6) anxiety and pain perception and 7) cognitive demand 
from symptoms limiting use of adaptive strategies. The persistence of these 
factors may lead to disability. 
A third mechanism that would confirm the coexistence of chronic pain and 
PTSD is the fear-avoidance model. Fear and avoidance may occur in response 
to chronic pain and may also be a symptom of PTSD 102. In chronic pain, fear-
avoidance occurs in response to the avoidance of movement that would increase 
pain sensation. In general, physiological symptoms such as increased blood flow, 
heart rate, or muscle tension may increase pain sensation and emphasize fear 
towards activities that will result in avoidance of such activities 103. For PTSD, a 
characteristic symptom is the fear of thinking about or talking about the stressful 
experience, a symptom that would culminate in avoidance of activities or 
situations associated with the traumatic experience. In addition, Otis et al in 2003 
discussed the triple vulnerability model as a fourth hypothesis linking the 
coexistence of chronic pain and PTSD 102. The triple vulnerability model is 
characterized by a generalized biological vulnerability, a generalized 
psychological vulnerability and a more specific psychological vulnerability. Keane 
and Barlow in 2002 adapted this model to propose a hypothesis for the 
development of PTSD 104. They suggested that in order to develop PTSD one 
must develop anxiety and an unpredictable and uncontrolled emotional reaction 
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to an event that resembles the traumatic event. Thus, when negative affect and 
the sense of uncontrollability are present, PTSD may develop. Otis et al in 2003 
102 proposed an extrapolation of this model to chronic pain whereby the pain 
experience itself could be perceived as an unpredictable and uncontrollable 
sensation leading to a lack of personal control over the pain. This in turn may 
lead to feelings of low self-efficacy, negative affect and avoidance of daily life 
situations. In summary, four models have been presented linking chronic pain 
and PTSD. The relationship between chronic pain and PTSD may have 
implications in treatment outcome for both conditions.  
 
3.3.1. Summary 
 
A high prevalence of PTSD in chronic pain patients including TMD 
patients is a common finding in the epidemiological studies. Chronic pain patients 
with PTSD symptoms frequently report higher levels of pain, affective distress 
and disability than chronic pain patients without PTSD symptoms. In addition, 
chronic pain patients with symptomatology of PTSD are more often classified 
with a dysfunctional profile than an adaptive coper profile on the MPI profile 
classification and present with clinically significant psychological distress on 
several domains. Due to the fact that both patients with chronic pain and patients 
with PTSD present with common symptomatology such as depression, anxiety, 
and/or dysregulation of the HPA-axis, an overlap of symptoms has been 
proposed. These mutual characteristics as proposed in four mechanisms 
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described above may influence prognostic and treatment outcomes of chronic 
pain patients with symptoms of PTSD. 
 
3.4. PTSD, TMD and Treatment Outcomes 
 
The effectiveness of biobehavioral strategies for management of TMD has 
been evaluated in a number of studies 105, 106. In fact, biobehavioral approaches 
such as proprioceptive awareness training, relaxation, diaphragmatic breathing 
training and awareness and control of parafunctional activities have been 
indicated for short and long term management of TMDs, especially those with 
MM pain as the primary symptom 107. Similarly, psychological approaches are 
currently identified as a first choice for treatment of PTSD 108. Psychological 
treatments for PTSD include exposure therapy, which was first used by Black 
and Keane 109 to treat PTSD among combat veterans. Anxiety management that 
involves relaxation training, breathing retraining, trauma education, cognitive 
restructuring, or communication skill training can also have a favorable impact on 
the symptoms of PTSD 110. In addition to psychological treatment, 
pharmacotherapy for PTSD has also been suggested 111. In a recent report, Stein 
and coworkers systematically reviewed randomized controlled trials of 
pharmacotherapy for PTSD and concluded that medication should be considered 
as part of the treatment of PTSD. Although they could not demonstrate 
differences among classes of medication with regard to efficacy or better 
tolerance, the largest trials showing efficacy were those evaluating selective 
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serotonin re-uptake inhibitors. In addition, glucocorticoids (hydrocortisone) 112 
and propranolol 113 have been suggested to prevent development of PTSD.  
Regarding the coexistence of the two conditions, management of chronic 
pain patients with symptoms of PTSD should include treatment directed to the 
anxiety disorder and the pain disorder. In fact, simultaneous treatment of chronic 
pain and PTSD has been suggested in the literature4, 23. In view of the fact that 
chronic pain and PTSD may exacerbate each other’s symptoms, management 
accomplishment of chronic pain patients with PTSD symptoms may be 
compromised. For example, depression in chronic pain patients has been 
associated with poor treatment response 114 and prematurely abandoning 
treatment 115. In addition, a dysfunctional profile has been related to poor 
treatment outcome in TMD patients 15. It seems logical that addressing all 
coexistent factors in both disorders may potentially lead to favorable treatment 
outcome, although further studies are necessary to determine whether it is 
necessary to address both conditions simultaneously in order to observe 
patient’s improvement in general. Perhaps addressing one of the two conditions 
or even one aspect these conditions have in common such as depression and/or 
anxiety or sleep disturbances could be sufficient to have a positive treatment 
outcome in both chronic pain and PTSD.  
Unfortunately, only a small number of studies addressing treatment 
outcome in chronic pain patients with PTSD symptoms have been reported in the 
literature. For instance, Hickling et al noted that patients with post-traumatic 
headache meeting criteria for PTSD required significantly longer cognitive 
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behavioral treatment than controls 116. Recently, a case study evaluating the 
effects of PTSD treatment in chronic pain patients was reported 117. The patient 
sample was composed of six females not responding to standard pain 
interventions such as surgery, physical therapy and medication including 
selective serotonin re-uptake inhibitors, non-steroids antiinflammatory and 
anticonvulsants. The PTSD treatment included a number of psychological 
approaches such as imaginal and in vivo exposure, relaxation techniques, social 
support, anger management and pleasant event scheduling. The authors found 
reduction in PTSD symptoms, improvement in dysfunction associated with pain, 
such as working status and time spent in bed following treatment. There was, 
however, no subjective reduction in pain reported by the subjects.  
 
3.4.1. Summary 
 
Addressing all coexisting factors may be the key to successful treatment in 
chronic pain patients with symptoms of PTSD. Behavioral treatment seems to be 
a promising approach for both chronic pain and PTSD. In fact, it appears that 
targeting PTSD symptoms may improve treatment outcomes overall in chronic 
pain patients. Additionally, educational strategies aimed at increasing patients’ 
recognition of the potential association between PTSD and chronic pain may be 
helpful as well. However, the effect of such treatment has not been 
systematically evaluated. Further investigations are needed to evaluate long-term 
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treatment outcome and whether decreasing symptoms of PTSD has a positive 
effect in the treatment response of chronic pain patients.  
Based on the aforementioned review of literature, the purpose of this 
study was to evaluate differences between MM pain patients and TMJ pain 
patients who sought treatment in an orofacial pain center in regard to the 
prevalence of PTSD symptoms. A second aim of this study was to analyze the 
level of psychological dysfunction and its relationship in regard to the presence 
and impact of PTSD symptoms in MM pain patients and TMJ pain patients. We 
hypothesized that the prevalence of PTSD symptoms and the level of 
psychological distress would be higher in MM pain patients than in TMJ pain 
patients. In addition, given the complicated nature of PTSD symptoms we 
hypothesized that the presence of this symptomatology would influence the level 
of psychological dysfunction both in MM and TMJ pain patients in several 
domains.  
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Chapter 4. Experimental Design and Methods 
 
4.1. Participants  
 
This study was a retrospective analysis of psychometric and sleep 
disorders data obtained from patients during the initial visit at an orofacial pain 
clinic as part of a standard evaluation protocol. The patient sample was selected 
from patients seen at the Orofacial Pain Center at the University of Kentucky, 
College of Dentistry from 1997 to 2005. Patients with both a primary and 
secondary diagnosis of MM pain or both a primary and secondary diagnosis of 
TMJ pain according to the Research Diagnostic Criteria 27 were eligible to 
participate in this study. Patients with a single diagnosis of either MM pain or 
TMJ pain were also eligible. Patients with a primary diagnosis of TMJ pain and a 
secondary diagnosis of MM pain or vice versa were not eligible. As part of the 
Orofacial Pain Center protocol all participants already have signed the standard 
“Patient Registration/Consent form” upon arriving for their initial evaluation. 
All patients completed an orofacial pain questionnaire and a battery of 
psychological questionnaires as part of the initial evaluation/examination. The 
psychological questionnaires included the Symptom Check List-90-Revised 
(SCL-90-R) 118, the Multidimensional Pain Inventory (MPI) 119, the Pittsburgh 
Sleep Quality Index (PSQI) 120 and the PTSD Check list Civilian (PCL-C) 121. 
These questionnaires embrace an extensive variety of symptoms and behaviors 
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that are important tools to develop a thorough treatment/management plan for 
chronic pain patients.  
The Orofacial Pain Center initial evaluation/examination involves an 
extensive interview where a detailed patient’s history is taking followed by 
conduction of clinical examination. The main objective of the history-taking is to 
acquire an accurate description of the patient’s chief complaint; information about 
key elements of each complaint(s), including onset, location, intensity, duration 
and associated factors is obtained. In addition, a psychologic assessment is also 
obtained. The clinical examination is composed of physical measures such as 
blood pressure and pulse rate, cranial nerve examination, cervical evaluation, 
muscle palpation with special emphases on myofascial trigger points and pain 
referral, TMJ evaluation (palpation, loading, joints sounds, deviation and 
deflection), range of mandibular movement and an intraoral examination. For this 
study the examinations were performed by dentists with advanced training in the 
diagnosis of orofacial pain conditions. All examiners were trained in the Orofacial 
Pain Center of the University of Kentucky within the guidelines of the American 
Academy of Orofacial Pain 9. 
The total sample of patients was divided into two major groups: 
Masticatory muscle (MM) and temporomandibular joint (TMJ) group. The MM 
group comprised patients with a primary and, when given, a secondary diagnosis 
of masticatory muscle pain 27. The TMJ group comprised patients with a primary 
and, when given, a secondary diagnosis of TMJ/intracapsular pain 27. 
Subsequently, each group was divided in three subgroups according to the 
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presence of a reported stressor (s) and severity of PTSD symptoms. The 
diagnoses of PTSD symptoms were based on the PCL-C, which corresponds to 
the DSM-IV criteria for PTSD (Table 2). Both groups were subcategorized as “no 
stressor”, “negative PTSD symptoms”, “positive PTSD symptoms” according to 
the presence of stressor and degree of PTSD symptomatology reported on the 
PCL-C. A score of 41 is considered the cut-off point for clinical significance of 
PTSD symptomatology 122. The “no stressor” group comprised patients who did 
not report a stressor on the PCL-C. The “negative PTSD symptoms” group 
comprised patients who reported one or more stressor(s) on the PCL-C but did 
not meet criteria for PTSD symptoms (PCL-C score < 41). The “positive PTSD 
symptoms” group comprised patients who reported one or more stressor(s) on 
the PCL-C and met criteria for PTSD symptoms (PCL-C score ≥ 41). 
 
4.2. Inclusion Criteria  
  
Patients who presented with the following characteristics were included in the 
study: 
1. At least18 years of age. 
2. A single diagnosis of TMJ or MM pain or, when a secondary diagnosis was 
given, both primary and secondary diagnoses of either MM or TMJ pain 
according to the Research Diagnostic Criteria.  
3. Pain duration of at least three months.  
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4. Pain intensity of at least three on visual analogue scale.  
5. No stressor reported on the PCL-C for inclusion in the “no stressor” subgroup. 
6. Stressor(s) reported and PCL score < 41 for inclusion in the “negative PTSD 
symptoms” subgroup. 
7. Stressor(s) reported and PCL-C score ≥ 41 for the inclusion in the “positive 
PTSD symptoms” subgroup. 
 
4.3. Psychometric Measures  
 
For this study data from the SCL-90-R, MPI, PSQI and PCL-C were used. 
The SCL-90-R is a 90–item self–report inventory that is used to assess 
psychological symptoms and yield nine symptoms dimensions and three global 
indices of functioning. Patients were asked to rate each item on a 5-point scale 
(from 0 “not at all” to 4 “extremely”) for how much each item has distressed or 
bothered them during the last 7 days including the day of the examination. From 
the SCL-90-R the presence and extent of symptoms such as somatization, 
obsessive-compulsive, interpersonal sensitivity, anxiety, depression, hostility, 
phobic anxiety, paranoid ideation, and psychoticism were obtained. The reliability 
and validity of the SCL-90-R has been demonstrated in a great number of studies 
summarized by Derogatis in 1983 123. Test-retest reliabilities range from r = 0.78 
to 0.90 for non-patient samples, and internal consistencies range from 0.77 to 
0.90 118. 
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The MPI includes three sections and contains 61 questions, which 
furnishes data regarding pain severity, perceptions of how pain interferes with 
life, appraisal of the amount of support received from spouse or significant other, 
perceived life control, affective distress including rates of depressed mood, 
irritability, tension, and social and general activities. In addition, it provides a 
patient profile classification, which includes dysfunctional, interpersonally 
distressed and adaptive coper profiles. These three profiles are considered the 
prototypic profiles. The category “Dysfunctional” comprises patients who report a 
high level of pain, distress, and disability and who feel pessimistic and helpless 
about their condition. The category “Interpersonally distressed” includes patients 
with the same characteristics as “Dysfunctional” but who also report poor social 
support. The category “Adaptive coper” includes patients who report low levels of 
pain, disability, and distress. In addition, three other profile classifications may be 
given. These include hybrid, anomalous and unanalyzable profiles. The “Hybrid” 
profile represents a combination of prototypic profiles. The “Anomalous” profile 
comprises MPI scale scores that make no sense to established theory; reasons 
for such profile could be random responding, reading or responding difficulties, or 
faking bad or good. Finally, the “Unanalyzable” profile is given when data are 
missing, and therefore, statistical analyses of the scores are not possible. Kerns 
et al 119 have demonstrated the validity of the MPI across chronic pain patients 
119. Test–retest reliabilities range from r = 0.68 to 0.86 and internal consistencies 
range from 0.73 to 0.90 119. 
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The PSQI is an 18-item self-report measure used to appraise general 
sleep quality. It provides information regarding the number of hours spent in bed 
and asleep, sleep latency, frequency and reasons for awakening, difficulty 
returning to sleep after awakening, sleep efficiency and use of sleep medication. 
The PSQI has demonstrated test–retest stability (r = 0.85) and internal 
consistency (alpha= 0.83) and provides valid and reliable assessment to overall 
sleep quality and disturbance 120, 124.  
The PCL-C is a 17-item self-report measure, used to assess the incidence 
of significant stressor(s) and prevalence of PTSD symptomatology. Before 
completing the 17-item measure, the patient is asked to identify any significant 
stressors s/he has experienced on a 15-item experience list. The list includes 
military combat, violent attack, being kidnapped, taken hostage, terrorist attack, 
torture, incarceration, natural or man-made disaster, severe auto accident, being 
diagnosed with a life-threatening illness, sudden injury/serious accident, 
observed someone hurt or killed, learned that your child has a life-threatening 
illness, and “others”. Subsequently, the patient is asked to identify the most 
significant stressor, indicate the date of occurrence and appraise how much the 
most significant stressor has bothered her/him in the past month on the 17-item 
measure. In this segment, 17 items are rated on a 5-point scale (1: “not at all”, 2: 
“a little bit”, 3: “moderately”, 4: “quite a bit”, and 5 “extremely”; see table 2). The 
PCL-C has exhibited test-retest stability (r = 0.96), good overall internal 
consistency (alpha = 0.92), and provides a valid and reliable assessment of the 
presence of PTSD symptoms 122. 
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4.4 Statistics Analyses  
 
Initial analyses were conducted by comparing the two diagnostic (MM and 
TMJ) groups. Diagnostic, demographic, MPI profile, and prevalence of PTSD 
symptomatology data between the two groups were tested using chi-square 
analyses. Age, pain severity, and pain duration were tested using student’s t-
tests. After these initial comparisons, each diagnostic group was divided into 
three subgroups depending on prevalence and intensity of PTSD 
symptomatology (no stressor, negative PTSD symptoms and positive PTSD 
symptoms subgroup). Analysis of variance ANOVA was used to test differences 
between the two diagnostic groups and among the three subgroups with regard 
to data from the SCL-90-R, MPI, and PSQI. The potential for family-wise error 
due to multiple comparisons during ANOVA was controlled for by using the 
Bonferroni correction. Significance level for all other comparisons was set at 
p=.05. All statistical analyses were conducted using the Statistical Package for 
the Social Sciences, Release 11.0 (SPSS Inc; Chicago, III). 
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Table 2. The PTSD Checklist-Civilian Version (PCL-C) 125. 
1 Repeated, disturbing memories, thoughts, or images of the stressful experience 1 2 3 4 5 
2 Repeated, disturbing dreams of the stressful experience       
3 Suddenly acting or feeling as if the stressful experience were happening again (as 
if you were reliving it) 
     
4 Feeling very upset when something reminded you of the stressful experience      
5 Having physical reactions (e.g., heart pounding, trouble breathing, sweating) when 
something reminded you of the stressful event 
     
6 Avoiding thinking about or talking about the stressful experience or avoiding 
having feelings related to it 
     
7 Avoiding activities or situations because they reminded you of the stressful 
experience  
     
8  Trouble remembering important parts of the stressful experience       
9 Loss of the interest in activities that you used to enjoy      
10 Feeling distant or cut-off from other people       
11 Feeling emotionally numb or being unable to have loving feelings for those close 
to you  
     
12 Feeling as if your future somehow will be cut short      
13  Trouble falling or staying asleep       
14 Feeling irritable or having angry outbursts      
15 Having difficulty concentrating       
16 Being super alert, or watchful, or on-guard      
17 Feeling jumpy or easily startled       
PTSD: Post-traumatic Stress Disorder. 
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Chapter 5. Results 
5.1 Sample size, demographics characteristics, pain variables and 
prevalence of PTSD symptoms  
 
The total patient sample was comprised of 445 adult patients (male = 42; 
female = 403; mean age 37.25 ± 12.9 years). The MM pain group was composed 
of 242 patients (male = 23; female = 219) with a mean age of 38.27 ± 12.9 years. 
The TMJ pain group was composed of 203 patients (male = 19; female = 184) 
with a mean age of 36.0 ± 12.8 years. Pain severity measured by a visual 
analogue scale where “0” is no pain and “10” is the most extreme pain, was 6.9 ± 
1.9 and 6.4 ± 2.0 respectively for the MM group and TMJ group. Pain duration 
reported by patients was 42.9 ± 55.7 months and 46.7 ± 74.5 months 
respectively for the MM group and TMJ group. There were no significant 
differences between the two groups in regard to gender (p=.55), age (p=.739), 
pain severity (p=.053), pain duration (p=.108) and demographic characteristics 
(see table 3). 
Of the entire sample, 206 patients (46%; 48% of the MM group and 44% 
of the TMJ group) reported to have experienced one or more significant traumatic 
stressors. Fifty six patients (12.6%) of the total sample presented with 
symptomatology of PTSD. More patients in the MM group (14.9%) than in the 
TMJ group (9.9%), met criteria for PTSD symptoms, but the difference was not 
statistically significant (p=.280; see table 4).  
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In the MM group there were no significant differences among the three 
subgroups (no stressor, negative PTSD and positive PTSD symptoms 
subgroups) in regard to gender (p=.161), age (p=.384), pain severity (p=.986) 
and pain duration (p=.935). Significant differences, however, were found in 
smoking status (χ2=6.657; p=.036) and marital status (χ2 =18.961; p=.004) where 
patients in the “positive PTSD subgroup” were more likely to be smokers, 
divorced and less likely to be married than patients in the other two subgroups. 
Additionally, patients in the “positive PTSD symptoms” were more likely to be 
applying for or receiving disability than patients in the other two subgroups 
(χ2=24.476; p=.000).  
In the TMJ group there were no significant differences among the three 
subgroups in regard to gender (p=.425), age (p=.331), pain severity (p=.074), 
pain duration (p=.632) and smoking status (p=.125). Significant differences, 
however, were found on marital status where patients in the “positive PTSD 
subgroup” were more likely to be divorced and less likely to be married than 
patients in the other two subgroups (χ2= 18.961; p=.004). Additionally, patients in 
the “positive PTSD symptoms” were more likely to be applying for or receiving 
disability than patients in the other two subgroups (χ2=24.476; p=.000).  
With respect to the presence of a stressor and / or PTSD symptomatology, 
there were no significant differences between the MM and TMJ group in the 
“positive PTSD symptoms” subgroups in regard to gender (p=.288), age 
(p=.634), pain severity (p=.631), pain duration (p=.513), disability (p=.566) and 
demographic characteristics in general (p>.05). There were no significant 
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differences between the MM and TMJ group in the “negative PTSD symptoms” 
subgroup in regard to gender (p=.533), age (p=.462), pain severity (p=.063), pain 
duration (p=.370), disability (p=.503) and demographic characteristics in general 
(p>.05). There were also no significant differences between the MM and TMJ 
group in the “no stressor” subgroup in regard to age (p=.124), gender, (p=.410), 
pain duration (p=.632), disability (p=.052) and demographic characteristics in 
general (p>.05). A significant difference however, was found between the MM 
and TMJ groups in the “no stressor” in regard to pain severity with patients in the 
MM group reporting more severe pain than patients in the TMJ group.(p=.007). 
 
5.2 Psychometric Data  
5.2.1 SCL-90-R 
 
Analyses of SCL-90-R data revealed higher scores on all subscales for 
patients in the MM group as compared to patients in the TMJ group, although 
these differences were not statistically significant for most scales (see table 5 
and figure 1). In the MM group, there were significant differences among the 
three subgroups (p=.000) for all nine subscales of the SCL-90-R. Post hoc tests 
revealed that these differences were due to significant higher scores on the 
subscales in patients who reported a stressor and met criteria for PTSD 
symptoms (“positive PTSD symptoms” subgroup) than in the other two 
subgroups (see figure 2). The same pattern was observed for the TMJ subgroups 
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(p=.000; see figure 3) for all subscales. Only patients in the “positive PTSD 
symptoms” subgroups of both the MM and TMJ group reached levels of distress 
that were indicative of psychological dysfunction on almost all subscales of the 
SCL-90-R (T-Score ≥ 63; see figures 1, 2 and 3).  
Considering the presence of a stressor and / or PTSD symptomatology, 
there were no significant differences between the MM and TMJ group in the “no 
stressor” subgroups on the SCL-90-R scales. A significant difference, however, 
was found between the MM and TMJ groups in the “negative PTSD symptoms” 
subgroups on the “phobic anxiety” subscale of the SCL-90-R (p=.016). In 
addition, a significant difference was found between the MM and TMJ groups in 
the “positive PTSD symptoms” subgroups on the “somatization” subscale of the 
SCL-90-R (p=.010; see table 6). 
 
5.2.2 MPI and MPI profile classification 
 
Significant differences were found between the MM and TMJ groups on 
most MPI scales. The MM group had significant higher scores on “interference”, 
“affective distress” and “punishing responses” scales and presented with lower 
scores on “life control”, “support”, “distracting responses”, “activities away from 
home”, “social activities” and “general activities level” scales than the TMJ group 
(see table 7).  
In the MM group, there were significant differences among the three 
subgroups for the following scales of the MPI: “interference”, “life control”, 
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“affective distress”, “support” and “punishing responses” (see table 8). Post hoc 
tests revealed that the “positive PTSD symptoms” subgroup had significantly 
lower scores on the “life control” scale and significantly higher scores on the 
“affective distress” and “punishing responses” scales than the other two 
subgroups (see table 8). For the MPI scales “interference” and “support” 
significant differences were found between the “no stressor” and “positive PTSD 
symptoms” subgroup with patients in the “positive PTSD symptoms” subgroup 
reporting more “interference” and less “support” than patients in the “no stressor” 
subgroup (see table 8).  
In the TMJ group, there were significant differences among the three 
subgroups for the following scales of the MPI: “interference”, “life control”, 
“affective distress”, “punishing responses”, “distracting responses”, “activities 
away from home”, “social activities” and “general activity level” (see table 9). Post 
hoc tests revealed that the “positive PTSD symptoms” subgroup had significantly 
lower scores on the “life control”, “activities away from home”, “social activities” 
and “general activity level” scales and significantly higher scores on the “affective 
distress”, “punishing responses” and “distracting responses” scales than the 
other two subgroups (see table 9).  
Considering the presence of a stressor and / or PTSD symptomatology, 
there were no differences between the MM and TMJ groups in the “positive 
PTSD symptoms” subgroups. Significant differences however, were found 
between the MM and TMJ groups in the “no stressor” as well as in the “negative 
PTSD symptoms” subgroups with regard to three scales of the MPI with patients 
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in MM group reporting more life interference and affective distress and less life 
control (see table 10).  
Approximately 50% of all patients were classified in one of the three main 
MPI profiles. Significant differences were found between the MM group and the 
TMJ group with regard to the MPI main profile classification (see table 11; the 
three non-specific profiles were not analyzed). Patients in the MM group were 
more often classified as dysfunctional or interpersonally distressed than patients 
in the TMJ group.  
In the MM group, the patients in the “positive PTSD symptoms” subgroup 
were significantly more often classified as dysfunctional and patients in the “no 
stressor” and in the “negative PTSD symptoms” subgroups were more often 
classified as adaptive copers (see table 12).  
In the TMJ group, the patients in the “no stressor” and in the “negative 
PTSD symptoms” subgroups were more often classified as adaptive copers than 
patients in the “positive PTSD symptoms” (see table 12). 
Considering the presence of a stressor and / or PTSD symptomatology, 
there were no significant differences between the MM and TMJ group in the 
“positive PTSD symptoms” subgroups for the three MPI profile classifications 
(see table 13). However, a significant difference was found between the 
“negative PTSD symptoms” subgroups where patients in the MM group were 
more often classified as interpersonally distressed than patients in the TMJ group 
(see table 13). A significant difference was also found between the “no stressor” 
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subgroups where patients in the MM group were more often classified as 
dysfunctional than patients in the TMJ group (see table 13). 
  
5.2.3 PSQI 
 
Subjectively reported sleep problems were significant higher for the MM 
group than for TMJ group (see table 14). In the MM group, the subgroup “positive 
PTSD symptoms” reported more sleep problems on most scales of the PSQI 
than the subgroups “no stressor” and “negative PTSD symptoms” (see table 15). 
The same trends were seen with TMJ patients in the subgroup “positive PTSD 
symptoms” who reported more sleep problems on all scales of the PSQI than 
TMJ pain patients in the subgroups “no stressor” and “negative PTSD symptoms” 
(see table 16).  
There were no significant differences between the MM and TMJ groups in 
the subgroups “positive PTSD symptoms” for any of the scales of the PSQI. 
Significant differences, however, were seen between the MM and TMJ group in 
the “no stressor” as well as in the “negative PTSD symptoms” subgroups on most 
scales of the PSQI, with the MM group reporting more sleep-related problems 
than the TMJ group (see table 17). 
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Table 3. Demographic Characteristics. 
Variable MM Group 
N (%) 
TMJ group 
N (%) 
Chi-
square 
p 
Female 219 (90.5) 184 (90.6) 0.003 0.546 
Male  23(9.5) 19 (9.4)   
     
Married 142 (59.9) 117 (62.6) 3.49 0.322 
Single 57 (24.1) 51 (27.3)   
Divorced  32 (13.5) 17 (9.1)   
Widowed  6 (2.5) 2 (1.1)   
     
Full time employment 117 (48.3) 98 (48.3) 6.78 0.341 
Part time employment 28 (11.6) 21 (10.3)   
Unemployed 32(13.2) 36 (17.7)   
Disabled  27 (11.2) 15 (7.4)   
Retired  11 (4.5) 8 (3.9)   
Student  13 (5.4) 6 (3.0)   
     
Receiving or applying for 
disability  
37(15.6) 22 (10.9) 2.08 0.095 
     
Lawyer consult 18 (7.8) 9(4.6) 1.80 0.126 
     
Smoker 64 (26.9) 51 (25.1) 0.18 0.378 
MM: Masticatory Muscle; TMJ: Temporomandibular Joint. 
N: number of patients; %: percentage. 
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Table 4. Prevalence of Stressors and PTSD Symptoms. 
 MM Group 
N (%) 
TMJ Group 
N (%) 
Total 
N (%) 
No Stressor 126 (52.1) 113 (55.7) 239 (53.7) 
Negative PTSD symptoms 80 (33.1) 70 (34.5) 150 (33.7) 
Positive PTSD symptoms 36 (14.9) 20 (9.9) 56 (12.6) 
PTSD: Post-traumatic Stress Disorder. 
MM: Masticatory Muscle; TMJ: Temporomandibular Joint. 
N: number of patients; %: percentage. 
(χ2 =2.547; p=.280) 
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Table 5. SCL-90-R Symptom Dimension Means and Standard Deviations between MM and TMJ Groups. 
SCL-90-R Subscales  MM Group 
M (SD) 
TMJ Group 
M (SD) 
F 
 
p 
Somatization 61.8 (9.0) 
 
58.0 (10.1 2.536 0.112 
Obsessive-compulsive 57.7 (11.4) 
 
54.9 (11.9) 0.517 0.472 
Interpersonal sensitivity 54.9 (11.2) 
 
52.9 (10.9) 0.140 0.780 
Depression 57.9 (10.9) 
 
54.1 (10.7) .000 0.999 
Anxiety 55.9 (10.9) 
 
53.3 (11.3) 0.487 0.486 
Hostility 55.3 (10.1) 
 
53.1 (9.9) 0.126 0.723 
Phobic anxiety 50.9 (9.4) 
 
50.7 (9.3) .023 0.880 
Paranoid ideation 51.8 (10.8) 
 
49.5 (10.1) 1.323 0.251 
Psychoticism 55.9 (10.6) 
 
52.1 (9.7) 3.850 0.050* 
SCL-90-R: Symptom Check List- 90-Revised. 
MM: masticatory muscle; TMJ: temporomandibular joint.  
M: Mean; SD: Standard Deviation. 
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Table 6. Comparison of SCL-90-R Symptom Dimension Means and Standard Deviations between the MM and TMJ 
Groups on a Subgroup Level. 
SCL-90-R subscales  Trauma 
Grouping 
MM Group 
M(SD) 
TMJ Group 
M(SD) 
F p 
Somatization No stressor  
Negative PTSD 
Positive PTSD  
60.8 (8.3) 
60.5 (8.0) 
68.3 (10.9) 
56.8 (9.5) 
56.7 (9.6) 
70.4 (7.1) 
1.847 
1.897 
7.152 
.175 
.171 
.010* 
Obsessive-compulsive No stressor  
Negative PTSD 
Positive PTSD 
56.0 (11.0) 
55.5 (10.8) 
68.7 (7.8) 
53.2 (11.6) 
53.4 (10.2) 
69.5 (8.5) 
1.122 
.815 
.272 
.291 
.368 
.604 
Interpersonal 
sensitivity 
No stressor  
Negative PTSD 
Positive PTSD 
54.0 (10.4) 
51.5 (9.4) 
65.8 (11.7) 
52.3 (10.7) 
50.7 (9.7) 
64.4 (9.7) 
.130 
.051 
.670 
.718 
.821 
.417 
Depression No stressor  
Negative PTSD 
Positive PTSD 
56.5 (10.8) 
55.7 (9.5) 
68.0 (8.9) 
53.2 (10.7) 
52.3 (9.5) 
66.1 (6.4) 
.007 
.126 
.533 
.934 
.723 
.469 
Anxiety No stressor  
Negative PTSD 
Positive PTSD 
54.8 (10.2) 
52.6 (9.4) 
67.5 (9.7) 
52.1 (10.3) 
51.3 (10.9) 
67.2 (9.3) 
.015 
3.845 
.297 
.901 
.052 
.588 
Hostility No stressor  
Negative PTSD 
Positive PTSD 
53.5 (9.7) 
53.5 ( 8.4) 
65.8 (7.5) 
52.6 (9.3) 
51.1 (9.2) 
63.7 (8.9) 
.426 
.688 
.425 
.514 
.408 
.517 
Phobic anxiety No stressor  
Negative PTSD 
Positive PTSD 
49.0 (7.9) 
48.7 (6.6) 
62.1 (12.0) 
49.6 (8.3) 
49.5 (8.9) 
60.9 (9.8) 
.385 
5.965 
2.762 
.536 
.016* 
.102 
Paranoid ideation No stressor  
Negative PTSD 
Positive PTSD 
50.4 (9.5) 
49.4 (8.9) 
62.6 (12.6) 
48.0 (8.8) 
48.4 (9.3) 
62.0 (11.5) 
.358 
.015 
.683 
.550 
.903 
.412 
Psychoticism No stressor  
Negative PTSD 
Positive PTSD 
54.0 (10.0) 
52.4 (8.5) 
64.9 (11.7) 
51.1 (9.0) 
50.9 (8.2) 
62.8 (11.5) 
2.990 
.246 
.049 
.085 
.621 
.825 
 
SCL-90-R: Symptom Check List- 90-Revised. 
MM: Masticatory Muscle; TMJ: Temporomandibular Joint. 
M: Mean; SD: Standard Deviation. 
PTSD: Post-traumatic Stress Disorder. 
*: Statistically significant. 
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Table 7. Comparisons of MPI Scales Means and Standard Deviations between MM and TMJ Groups. 
MPI Scale  MM Group 
M(SD) 
TMJ Group 
M(SD) 
F p 
Interference  33.6 (16.0) 25.0 (15.0) 30.142 .000* 
Life control 49.4 (7.9) 53.0 (7.3) 26.405 .000* 
Affective distress 47.4 (9.6) 43.5 (10.4) 27.082 .000* 
Support  47.3 (11.1) 47.3 (10.0) 3.124 .045* 
Punishing responses  46.5 (8.6) 45.0 (7.1) 10.998 .000* 
Soliciting responses 49.9 (9.7) 48.1 (9.5) .423 .655 
Distracting responses  47.7 (9.7) 50.4 (40.2) 6.257 .002* 
Household chores  55.7 (9.1) 55.6 (9.6) 1.394 .249 
Outdoor work 54.6 (11.6) 54.1 (11.4) .166 .847 
Activities away from home  53.0 (10.0) 54. 2 (10.0) 5.114 .006* 
Social activities  51.8 (10.0) 52.9 (9.4) 4.283 .014* 
General activity level  55.2 (9.9) 55.9 (9.7) 2.743 .065 
MPI: Multidimensional Pain Inventory. 
MM: Masticatory Muscle; TMJ Temporomandibular Joint. 
M: Means; SD: Standard Deviations. 
*: Statistically significant. 
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Table 8. Comparisons of MPI Scales Means and Standard Deviations among the Three Subgroups in the MM Group. 
MPI Scale  No stressor  
M(SD) 
Negative 
PTSD 
M(SD) 
Positive PTSD 
M(SD) 
F P 
Interference 31.7a (16.2) 33.9a,b (15.5) 39.4b (14.2) 3.382 .036* 
Life control 50.2a (8.0) 50.7 a (7.0) 43.8b (6.9) 11.842 .000* 
Affective distress 46.0a (9.6) 46.7a (9.7) 53.9b (6.7) 10.464 .000* 
Support 48.6 a (8.9)  47.3a,b (12.8) 42.5b(13.3) 3.299 .039* 
Punishing responses 45.6a (8.0) 45.7a (7.8) 51.5b (10.3) 5.690 .004* 
Soliciting responses 49.5 (8.8) 48.0 (10.9) 49.1 (10.2) .422 .656 
Distracting responses 48.2 (9.5) 47.0 (9.9) 47.5 (10.6) .308 .735 
Household chores 55.9 (8.7) 55.2 (9.8) 55.7 (9.4) .172 .842 
Outdoor work 53.6 (11.4) 56.5  (11.6) 53.8 (12.0) 1.601 .204 
Activities away from home 54.0 (10.0) 52.0  (10.3) 51.4 (10.0) 1.415 .245 
Social activities 52.0 (10.0) 51.9 (10.2) 50.6 (9.7) .301 .740 
General activity level 55.5 (9.4) 55.4 (10.6) 54.2 (10.3) .240 .786 
MPI: Multidimensional Pain Inventory. 
MM: Masticatory Muscle. 
M: Means; SD: Standard Deviation. 
PTSD: Post-traumatic Stress Disorder. 
ab When superscripts are the same between 2 groups , post-hoc comparisons indicates no significant differences 
between group means. When superscripts are different, post-hoc comparisons indicate significant difference between 
group means at p≤.05 
*: Statistically significant. 
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Table 9. Comparisons of MPI Scales Means and Standard Deviations among the Three Subgroups in the TMJ 
Group. 
MPI Scale  No stressor  
M(SD) 
Negative 
PTSD 
M(SD) 
Positive PTSD 
M(SD) 
F P 
Interference 23.3a (13.8) 23.7a (13.0) 39.6b (17.8) 11.962 .000* 
Life control 53.3a (7.5) 53.9 a (5.6) 47.5b (9.4) 6.532 .002* 
Affective distress 42.5a (9.7) 42.5a (10.5) 53.4b (9.7) 10.794 .000* 
Support 48.3 (9.4)  45.2 (11.2) 49.1 (8.6) 1.959 .144 
Punishing responses 43.9a (6.0) 45.3a (7.1) 50.3b (10.5) 5.628 .004* 
Soliciting responses 48.8 (10.2) 46.5 (8.6) 50.8 (8.0) 1.644 .196 
Distracting responses 47.4a (8.7) 46.4a (8.7) 50.5b (7.2) 5.825 .004* 
Household chores 56.3 (9.3) 55.5 (9.4) 52.2 (11.6) 1.608 .203 
Outdoor work 53.4 (11.4) 56.5  (10.0) 52.9 (15.0) .862 .424 
Activities away from home 54.9a (9.8) 55.0a  (9.6) 47.4b (10.8) 5.296 .006* 
Social activities 53.8a (9.4) 53.3a (8.5) 46.9b (10.3) 4.870 .009* 
General activity level 56.4a (9.3) 56.7a (8.6) 50.0b (13.0) 4.147 .017* 
MPI: Multidimensional Pain Inventory. 
TMJ: Temporomandibular Joint. 
M: Means; SD: Standard Deviation. 
PTSD: Post-traumatic Stress Disorder. 
ab When superscripts are the same between 2 groups , post-hoc comparisons indicates no significant differences 
between group means. When superscripts are different, post-hoc comparisons indicate significant difference between 
group means at p≤.05 
*: Statistically significant. 
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Table 10. Comparison of MPI Scales Means and Standard Deviations between MM and TMJ group on the  
Subgroup Level. 
MPI Scale  Trauma Grouping MM Group 
M(SD) 
TMJ Group 
M(SD) 
F p 
Interference  No stressor  
Negative PTSD 
Positive PTSD  
31.7 (16.2) 
33.9(15.5) 
39.4 (14.2) 
23.3 (13.8) 
23.7 (13.0) 
39.6 (17.8) 
17.991 
18.765 
.002 
.000* 
.000* 
.961 
Life control No stressor  
Negative PTSD 
Positive PTSD 
50.2 (8.0) 
50.7 (7.0) 
43.8 (6.9) 
53.3 (7.5) 
53.9 (5.6) 
47.5 (9.4) 
9.228 
9.374 
2.817 
.003* 
.003* 
.099 
Affective distress No stressor  
Negative PTSD 
Positive PTSD 
46.0 (9.6) 
46.7 (9.7) 
53.9 (6.7) 
42.5 (9.7) 
42.5 (10.5) 
53.4 (9.7) 
7.864 
6.720 
.054 
.005* 
.010* 
.817 
Support  No stressor  
Negative PTSD 
Positive PTSD 
48.6 (8.9) 
47.3 (12.8) 
42.5 (13.3) 
48.3 (9.4) 
45.2 (11.2) 
49.1 (8.6) 
.059 
.874 
2.989 
.808 
.352 
.092 
Punishing responses  No stressor  
Negative PTSD 
Positive PTSD 
45.6 (8.0) 
45.7 ((7.8) 
51.5 (10.3) 
43.9 (6.0) 
45.3 (7.1) 
50.3 (10.5) 
2.728 
.089 
.125 
.100 
.767 
.725 
Soliciting responses No stressor  
Negative PTSD 
Positive PTSD 
49.5 (8.8) 
48.0 (10.9) 
49.1 (10.2) 
48.8 (10.2) 
46.5 (8.6) 
50.8 (8.0) 
.282 
.781 
.293 
.596 
.379 
.591 
Distracting responses  No stressor  
Negative PTSD 
Positive PTSD 
48.2 (9.5) 
47.0 (9.9) 
47.5 (10.6) 
47.4 (8.7) 
46.4 (8.7) 
50.5 (7.2 ) 
.351 
.120 
.922 
.554 
.729 
.343 
Household chores  No stressor  
Negative PTSD 
Positive PTSD 
55.9 (8.7) 
55.2 (9.8) 
55.7 (9.4) 
56.3 (9.3) 
55.5 (9.4) 
52.2 (11.6) 
.106 
.045 
1.498 
.745 
.833 
.226 
Outdoor work No stressor  
Negative PTSD 
Positive PTSD 
53.6 (11.4) 
56.5 (11.6) 
53.8 (12.0) 
53.4 (11.6) 
55.6 (10.0) 
52.9 (15.0) 
.010 
.244 
.058 
.921 
.622 
.811 
Activities away from home  No stressor  
Negative PTSD 
Positive PTSD 
54.0 (10.0) 
52.0 (10.3) 
51.4 (10.0) 
54.9 (9.8) 
55.0 (9.6) 
47.4 (10.8) 
.486 
3.233 
1.994 
.486 
.074 
.164 
Social activities  No stressor  
Negative PTSD 
Positive PTSD 
52.0 (10.0) 
51.9 (10.2) 
50.6 (9.7) 
53.8 (9.4) 
53.3 (8.5) 
46.9 (10.3) 
1.797 
.880 
1.789 
.181 
.350 
.187 
General activity level  No stressor  
Negative PTSD 
Positive PTSD 
55.5 (9.4) 
55.4 (10.6) 
54.2 (10.3) 
56.4 (9.3) 
56.7 (8.6) 
50.0 (13.0) 
.556 
.655 
1.684 
.457 
.420 
.200 
MPI: Multidimensional Pain Inventory.  
M: Mean; SD: Standard Deviation. 
MM: Masticatory Muscle; TMJ: Temporomandibular Joint.  
PTSD: Post-traumatic Stress Disorder.*: Statistically significant. 
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Table 11. MPI Profile Classification between the MM and TMJ Groups. 
MPI profile MM Group 
N (%) 
TMJ Group 
N (%)  
Chi-square p 
Dysfunctional 46 (34.8) 21 (24.7) 9.328 .002* 
Interpersonally distressed 27 (20.5) 10 (11.8) 7.811 .005* 
Adaptive coper 59 (44.7) 54 (63.5) .221 .638 
MPI: Multidimensional Pain Inventory  
MM: Masticatory Muscle; TMJ: Temporomandibular Joint. 
N: Number of patients, %: percentage 
*: Statistically significant. 
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Table 12. MPI Profile Classification among the Three Subgroups in the MM Group and in the TMJ Group. 
 Trauma Grouping 
MPI profile 
No stressor 
 
Negative 
PTSD 
Positive 
PTSD 
Chi 
square 
p 
   MM Group      
Dysfunctional 25 (36.8) 12 (27.9) 9 (42.9) 9.440 .009* 
Interpersonally distressed 11 (16.2) 10 (23.3) 6 (28.6) 1.556 .459 
Adaptive coper  32 (47.1) 21 (48.8) 6 (28.6) 17.320 .000* 
   TMJ group      
Dysfunctional 7 (15.2) 7 (25.9) 7 (58.3) 0.000 1.00 
Interpersonally distressed 6 (13.0) 2 (7.4) 2 (16.7) 3.200 .202 
Adaptive coper  33 (71.7) 18 (66.7) 3 (25.0) 25.00 .000* 
MPI: .Multidimensional Pain Inventory:  
MM: Masticatory Muscle; TMJ: Temporomandibular Joint.  
N: Number of patients; %: percentage.  
PTSD: Post-traumatic Stress Disorder. 
*: Statistically significant 
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Table 13 Comparisons of MPI Profile Classification between MM and TMJ Group on the Subgroup Level. 
MPI profile Trauma Grouping  MM Group 
N (%) 
TMJ Group 
N (%) 
Chi-square p 
Dysfunctional No stressor  
Negative PTSD 
Positive PTSD 
25 (19.8) 
12 (15.0) 
9 (25.0) 
7 (6.2) 
7 (10.0) 
7 (35.0) 
10.125 
1.316 
.250 
.001* 
.251 
.617 
Interpersonally distressed No stressor  
Negative PTSD 
Positive PTSD 
11 (8.7) 
10 (12.5) 
6 (16.7) 
6 (5.3) 
2 (2.9) 
2 (10.0) 
1.417 
5.330 
2.000 
.225 
.021* 
.157 
Adaptive coper  No stressor  
Negative PTSD 
Positive PTSD 
32 (25.4) 
21 (26.3) 
6 (16.7) 
33 (29.2) 
18 (25.7) 
3 (15.0) 
.015 
.231 
1.000 
.901 
.631 
.317 
MPI: .Multidimensional Pain Inventory:  
MM: Masticatory Muscle; TMJ: Temporomandibular Joint.  
N: Number of patients; %: percentage.  
PTSD: Post-traumatic Stress Disorder. 
*: Statistically significant. 
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Table 14. PSQI Means and Standard Deviation between the MM and TMJ Group. 
PSQI Scales MM group 
M (SD) 
TMJ group 
M (SD) 
F p 
Subjective sleep quality  1.6 (0.8) 1.3 (0.8) 13.228 .000* 
Sleep latency 1.6 (1.0) 1.3 (1.0) 10.114 .002* 
Sleep duration 1.3 (1.0) 1.1 (1.0) 5.370 .021* 
Habitual sleep efficiency 1.0 (1.1) 0.7 (1.0) 6.774 .010* 
Sleep disturbances  1.8 (0.6) 1.6 (0.6) 9.114 .003* 
Use of sleep medication 1.4 (1.4) 0.9 (1.2) 15.359 .000* 
Daytime dysfunction  1.3 (0.8) 1.1 (0.8) 6.046 .014* 
PSQI total score  10.0 (4.4) 8.0 (4.2) 22.346 .000* 
PSQI: Pittsburgh Sleep Quality Index.  
MM: Masticatory Muscle; TMJ: Temporomandibular Joint. 
M: Mean; SD: Standard Deviation. 
*: Statistically significant. 
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Table 15. PSQI Means and Standard Deviations among the Three Subgroups in the MM group. 
 No stressor  
M (SD) 
Negative 
PTSD 
M (SD) 
Positive PTSD 
M (SD) 
 
F 
 
p 
Subjective sleep quality  1.6 (0.9) 1.5 (0.8) 1.9 (0.8) 2.315 .101 
Sleep latency 1.6a (1.0) 1.5a (1.0) 2.2b (0.9) 6.339 .002* 
Sleep duration 1.2a (0.9) 1.4a, b (1.0) 1.7b (1.1) 3.045 .050* 
Habitual sleep efficiency 0.9 (1.1) 1.0 (1.1) 1.5 (1.9) 2.842 .060 
Sleep disturbances  1.7a (0.6) 1.7a (0.6) 2.2b (0.6) 9.063 .000* 
Use of sleep medication 1.3 (1.4) 1.3 (1.3) 1.7 (1.4) .738 .479 
Daytime dysfunction  1.3a (0.8) 1.2a (0.7) 1.8b 0.8) 6.326 .002* 
PSQI total score  9.7a (4.4) 9.6a (4.4) 13.0b (4.0) 7.871 .000* 
PSQI: Pittsburgh Sleep Quality Index.  
MM: Masticatory Muscle; M: Mean; SD: Standard Deviation. 
PTSD: Post-traumatic Stress Disorder. 
ab When superscripts are the same between 2 groups , post-hoc comparisons indicates no significant differences 
between group means. When superscripts are different, post-hoc comparisons indicate significant difference between 
group means at p≤.05 
*: Statistically significant 
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Table 16. PSQI Means and Standard Deviations among the Three Subgroups in the TMJ Group. 
 No stressor  
M (SD) 
Negative 
PTSD 
M (SD) 
Positive PTSD 
M (SD) 
 
F 
 
p 
Subjective sleep quality  1.2a (0.8) 1.4a (0.8) 1.9 b (0.9) 6.529 .002* 
Sleep latency 1.2a (1.0) 1.3a (1.0) 2.0b (1.1) 5.204 .006* 
Sleep duration 1.1a (0.9) 0.9a (0.9) 1.8b (1.2) 5.772 .004* 
Habitual sleep efficiency 0.7a (1.0) 0.5a (0.9) 1.5b (1.3) 5.619 .004* 
Sleep disturbances  1.5a (0.6) 1.6a (0.6) 2.2b (0.6) 10.435 .000* 
Use of sleep medication 0.7a (1.1) 1.0a, b (1.3) 1.4b (1.4) 3.437 .034* 
Daytime dysfunction  1.0a (0.8) 1.0a (0.8) 1.9b (0.8) 10.200 .000* 
PSQI total score  7.4a (4.0) 7.9a (3.8) 13.0b (4.4) 13.611 .000* 
PSQI: Pittsburgh Sleep Quality Index.  
TMJ: Temporomandibular Joint; M: Mean; SD: Standard Deviation. 
PTSD: Post-traumatic Stress Disorder. 
ab When superscripts are the same between 2 groups , post-hoc comparisons indicates no significant differences 
between group means. When superscripts are different, post-hoc comparisons indicate significant difference between 
group means at p≤.05 
*: Statistically significant 
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Table 17. Comparison of PSQI scales between MM and TMJ Group on the Subgroup Level. 
  
Trauma grouping 
MM group 
M (SD) 
TMJ group 
M (SD) 
 
F 
 
p 
Subjective sleep quality  No stressor  
Negative PTSD 
Positive PTSD 
1.6 (0.9) 
1.5 (0.8) 
1.9 (0.8) 
1.2 (0.8) 
1.4 (0.8) 
1.9 (0.9) 
13.242 
1.601 
.001 
.000* 
.208 
.976 
Sleep latency No stressor  
Negative PTSD 
Positive PTSD 
1.6 (1.0) 
1.5 (1.0) 
2.2 (0.9) 
1.2 (1.0) 
1.3 (1.0) 
2.0 (1.1) 
8.687 
.987 
.390 
.004* 
.322 
.535 
Sleep duration No stressor  
Negative PTSD 
Positive PTSD 
1.2 (0.9) 
1.4 (0.9) 
1.7 (1.1) 
1.1 (0.9) 
0.9 (0.9) 
1.8 (1.2) 
.714 
8.361 
.063 
.399 
.004* 
.803 
Habitual sleep efficiency No stressor  
Negative PTSD 
Positive PTSD 
0.9 (1.1) 
1.0 (1.1) 
1.4 (1.9) 
0.7 (1.0) 
0.5 (0.9) 
1.4 (1.3) 
1.735 
6.804 
.000 
.189 
.010* 
.992 
Sleep disturbances  No stressor  
Negative PTSD 
Positive PTSD 
1.7 (0.6) 
1.7 (0.6) 
2.2 (0.6) 
1.5 (0.6) 
1.6 (0.6) 
2.7 (0.6) 
9.011 
.544 
.157 
.003* 
.462 
.694 
Use of sleep medication No stressor  
Negative PTSD 
Positive PTSD 
1.3 (1.4) 
1.3 (1.3) 
1.7 (1.4) 
0.7 (1.1) 
1.0 (1.3) 
1.4 (1.4) 
15.097 
1.626 
.418 
.000* 
.204 
.521 
Daytime dysfunction  No stressor  
Negative PTSD 
Positive PTSD 
1.3 (0.8) 
1.2 (0.7) 
1.8 (0.8) 
1.0 (0.8) 
1.0 (0.8) 
1.9 (0.8) 
5.569 
1.224 
.413 
.019* 
.270 
.524 
PSQI total score  No stressor  
Negative PTSD 
Positive PTSD 
9.7 (4.4) 
9.6 (4.1) 
13.0 (4.0) 
7.4 (4.0) 
7.9 (3.8) 
12.7 (4.0) 
15.972 
6.559 
.058 
.000* 
.011* 
.810 
PSQI: Pittsburgh Sleep Quality Index.  
MM: Masticatory Muscle; TMJ: Temporomandibular Joint. 
M: Mean; SD: Standard Deviation. 
PTSD: Post-traumatic Stress Disorder. 
*: Statistically significant. 
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Fig. 1. SCL-90-R Scores by Masticatory Muscle & Temporomandibular Joint Group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SCL-90-R: Symptom Check List- 90-Revised. 
T-score ≥ 63: levels indicative of psychological dysfunction. 
SOM: somatization; OC: obsessive-compulsive; IS: interpersonal sensitivity;  
DEP: depression; ANX: anxiety; HOS: hostility; PhANX: phobic anxiety;  
PAR: paranoid ideation, PSY: psychoticism. 
MM: Masticatory Muscle; TMJ: Temporomandibular Joint. 
 
 
Figure 2. SCL-90-R Score by PTSD Status in the Masticatory Muscle Group. 
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SCL-90-R: Symptom Check List- 90-Revised. 
PTSD: Post-traumatic Stress Disorder. 
T-score ≥ 63: levels of indicative psychological dysfunction. 
Neg: negative; Pos: positive. 
SOM: somatization; OC: obsessive-compulsive; IS: interpersonal sensitivity;  
DEP: depression; ANX: anxiety; HOS: hostility; PhANX: phobic anxiety;  
PAR: paranoid ideation, PSY: psychoticism. 
*: Post-hoc comparisons indicate significant difference between the “positive PTSD symptoms” and the other two 
subgroups (p=.000).  
40
45
50
55
60
65
70
75
80
SO
M OC IS DE
P
AN
X
HO
S
Ph
AN
X
PA
R
PS
Y
T-
Sc
or
e
MM Group (n=242) TMJ Group (n=202)
 
 53
40
45
50
55
60
65
70
75
80
SO
M OC IS DE
P
AN
X
HO
S
Ph
AN
X
PA
R
PS
Y
T-
Sc
or
e
No stressor Neg PTSD symptoms Pos PTSD symptoms 
Figure3. SCL-90-R Score by PTSD Status in the Temporomandibular Joint Group. 
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SCL-90-R: Symptom Check List- 90-Revised. 
PTSD: Post-traumatic Stress Disorder. 
T-Score ≥ 63: levels indicative psychological dysfunction. 
Neg: negative; Pos: positive.  
SOM: somatization; OC: obsessive-compulsive; IS: interpersonal sensitivity;  
DEP: depression; ANX: anxiety; HOS: hostility; PhANX: phobic anxiety;  
PAR: paranoid ideation, PSY: psychoticism. 
*: Post-hoc comparisons indicate significant difference between the “positive PTSD symptoms” and the other two 
subgroups (p=.000) 
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Chapter 6. Discussion 
 
Post-traumatic Stress Disorder symptoms were reported by 14.9% of 
patients with MM pain and by 9.9% of patients with TMJ pain. Analyses of the 
total sample revealed an overall prevalence of 12.6% for PTSD symptoms. The 
findings of this study are in agreement with previous studies in orofacial pain 
populations 7, 19. In a recent investigation, de Leeuw et al 19 reported an overall 
prevalence rate of 14.7 % for PTSD symptoms in orofacial pain patients. Similar 
to previous studies, we observed a higher prevalence rate of PTSD symptoms in 
MM pain patients when compared to TMJ/intracapsular pain patients 19, 26. The 
higher prevalence of PTSD symptoms in the MM group is not surprising given 
that several studies reported higher levels of psychological distress in MM pain 
patients than in TMJ pain patients 15, 14, 17. Moreover, studies have shown that 
MM pain patients report more exposures to stressful life events than TMJ pain 
patients 20,35.  
Surprisingly, the overall prevalence rate of 12.6% of PTSD symptoms was 
similar to the lifetime prevalence of PTSD (1% to 14%) in the general population 
estimated by the DSM-IV 1. Current PTSD prevalence rates, however, appear to 
be less than 10% 126, 127, 128. Given these data, the prevalence of current PTSD 
symptomatology in the present study can be considered somewhat elevated. 
Nevertheless, our findings disagree with previous studies in chronic pain 
(fibromyalgia), where extremely elevated prevalence rates (approximately 55%) 
of PTSD symptoms have been reported 4, 5. Such discrepancy could potentially 
be explained by individual differences among these study populations, such as 
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social support, family history, personality variables and preexisting mental 
disorders that may be involved in the development of PTSD 1, or methodological 
differences between the studies. On the other hand, the discrepancy between 
our studies and these other two studies could be a reflection of an increased 
vulnerability for PTSD symptoms in patients with chronic widespread pain 
conditions when compared to patients with a more localized pain condition such 
as TMD. Further studies are needed to clarify whether such relationship exists.  
Previous studies have shown a relationship between the presence of 
PTSD symptoms and increased pain level 4, 18. We were unable to confirm this 
relationship because in the present study there was no significant difference for 
both MM and TMJ among the PTSD subgroups in regard to pain severity. Such 
conflicting findings could potentially be explained due to methodological 
differences or different pain populations between this study and the previous 
studies. On the other hand, in accordance with these studies and two other 
studies in orofacial pain populations 8, 19 the present study indicates a positive 
relationship between PTSD symptoms and disability. Sharp et al in 2001 
described a model to explain the overlap of symptoms between chronic pain and 
PTSD, the mutual maintenance hypothesis, whereby chronic pain and PTSD 
may reciprocally maintain or exacerbate the symptoms of both conditions that 
may lead to disability 101. Nonetheless, a causal relationship between PTSD and 
disability can not be established with the present study due to its retrospective 
nature; further studies are need to determine whether such relationship exist. 
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The SCL-90-R data revealed somewhat higher scores for patients in the 
MM group than for patients in the TMJ group. An interesting finding of this study 
was that only TMD patients (both of the MM group and TMJ group) with PTSD 
symptomatology presented with elevated levels of psychological dysfunction (T-
score ≥ 63) on the SCL-90-R. Evidence suggests that scores equal or greater 
than 63 are considered by most authors as the “cut-off” point for clinical 
significance 129. Our findings are consistent with those presented by de Leeuw et 
al 19. They observed that higher levels of psychological distress were limited to 
TMD patients who met criteria for PTSD symptomatology. Our findings are also 
similar to previous studies with headache 98 and neuropathic pain patients 99 
where elevated levels of psychological distress were also linked to only patients 
meeting criteria for PTSD symptoms. These findings differ from those of previous 
studies, suggesting that MM pain patients report more psychological distress in 
general than TMJ pain patients 14, 15. The discrepancy between our findings and 
the findings reported by these previous studies could be explained by the fact 
that these studies did not screen for PTSD symptomatology. Furthermore, this 
study contradicts the widely held concept that TMD patients are in general 
psychologically distressed. According to our findings, high levels of psychological 
dysfunction as measured on the SCL-90-R are likely to be associated with the 
presence of PTSD symptoms and not likely to be associated with TMD patients 
in general. Consequently, elevated SCL-90-R scores generally may indicate the 
presence of PTSD symptoms.  
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Significant differences were found between the MM and TMJ groups on 
most scales of the MPI. Our results are in agreement with previous studies of 
TMD patients that indicate higher levels of psychological distress and life 
interference in muscle pain patients than in TMJ pain patients 15, 17, 63, 130. The 
fact that patients in the MM group presented with more life interference and 
higher levels of affective distress than patients in the TMJ group could potentially 
be a consequence of how high levels of psychological distress may interfere with 
a patient’s coping skills. However, it is not possible to determine whether such an 
association exists with the present study; further studies are needed to elucidate 
this matter. It is noteworthy that no significant differences were found between 
the two diagnostic groups in the “positive PTSD symptoms” subgroups on the 
MPI scales. These findings are consistent with those findings reported by de 
Leeuw et al 19. It is remarkable that TMJ pain patients potentially exhibited 
deficient coping skills and present with decreased level of social activities when 
the presence of PTSD is considered. Indeed, the severity of anxiety and life 
interference may be associated with the severity of PTSD symptoms in chronic 
pain patients generally 23. Taken together, these findings further support the 
necessity for PTSD screening among TMD patients.  
It appears that symptoms of PTSD may potentially interfere with patient’s 
capacity to cope with her/his pain. This finding is also reflected in the fact that 
dysfunctional MPI profiles  were more common than the adaptive coper profile 
amongst patients with PTSD symptomatology. Our results are in accordance with 
those reported in chronic pain patients with PTSD symptomatology 4, 19, 100 who 
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also presented more often with a dysfunctional profile than an adaptive coper 
profile. In addition, dysfunctional profiles may be associated with higher levels of 
anxiety 100 which, in turn, may potentially exacerbate the pain condition.  
A potential explanation for these findings is the dysregulation of the HPA-
axis that has been associated with inadequate coping strategies 50. Alteration in 
the physiology of the HPA-axis may be related to somatic complaints such as 
myalgia, arthralgia and sleep disturbances in the absence of recognized 
pathological condition 131. In addition, early life events, such as preterm birth, 
parental divorce, or childhood abuse may result in physiological vulnerability 
expressed as persistent sensitization of the HPA-axis 46. In fact, dysregulation of 
the HPA-axis has also been linked to the development of both chronic pain 13, 50 
and PTSD, that is characterized by maladaptive behavior 132. In turn, this 
maladaptive behavior can be understood as a lack of inhibitory control 133.  
Living systems are described as “self-organizing dynamic systems” that 
combine autonomic, attentional and affective systems into a functional and 
structural network 133,134. These systems are likely to be controlled by inhibitory 
processes that allow them the necessary flexibility for efficient functioning 
through self-regulation and adaptability of the organism in the face of changing 
environmental demands 133,134. Thayer and Lane in 2000 described how arousal 
associated with anxiety represents a dis-inhibition of circuits that are normally 
under inhibitory control 134. Thus inhibitory failure may lead to maladaptive 
behavior at multiple levels of the organism which, in turn, may prevent recovery 
or a return to normal functioning. 
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Several studies have demonstrated a relationship between chronic pain 
and sleep disturbances 17,30, 135. In agreement with previous studies 17, 64, our 
findings revealed that the patients in the MM group reported more sleep 
problems than patients in the TMJ group. It is unlikely that these findings would 
be a consequence of increased pain severity 30 or increased pain duration 16 
since in the current study no significant differences in regard to pain severity and 
duration were found between the two groups. A possible explanation for these 
findings could be the presence of psychological distress that has been 
associated with sleep disturbances pathogeneses in a number of studies 30, 64, 
136. 
Both MM and TMJ pain patients in the “positive PTSD symptoms” 
subgroup reported more sleep problems on most scales of the PSQI than MM 
and TMJ pain patients in the “no stressor” and in the “negative PTSD symptoms” 
subgroups. This finding is not extraordinary if the presence of PTSD symptoms is 
considered. Indeed, according to the DSM-IV 1 sleep disturbances are included 
in the symptomatology of PTSD. It is not possible to determine with the present 
study design whether the sleep disturbances were a response to the pain 
experience itself or whether they were associated to the symptomatology of 
PTSD. These findings may be associated to an overlap of symptoms between 
chronic pain and PTSD symptoms 23, 101 which in turn may exacerbate the 
symptomatology of both conditions. On the other hand, it also could be a 
response to alterations of HPA-axis, a common characteristic found in chronic 
pain patients as well as in PTSD patients 46. Indeed, the HPA-axis plays 
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important roles in maintaining alertness and modulating sleep 137. In addition, 
dysregulation of the HPA-axis has been associated with sleep disturbances in a 
number of studies 50, 138. Nonetheless, sleep disturbances are remarkably 
common in chronic pain and in PTSD and should be addressed since it could be 
a major factor in chronic pain and PTSD symptomatology.  
Given the coexistence of chronic pain and PTSD, appropriate 
management of chronic pain patients with symptoms of PTSD may possibly 
require treatment of both the anxiety disorder and the pain disorder. There are 
only a small number of studies addressing treatment outcomes in chronic pain 
patients with PTSD symptoms 116, 117. Research suggests favorable treatment 
outcomes targeting symptoms of PTSD in chronic pain patients such as 
decreased PTSD symptomatology and improvement in dysfunction associated to 
pain 117. The fact that in the present study, TMD patients with PTSD 
symptomatology were more often classified with a dysfunctional profile than an 
adaptive coper profile may further complicate interventions in such patients. 
Indeed, a dysfunctional profile has been related to poor treatment outcome 
overall in TMD patients and to treatment failure 15. In addition, failure to recognize 
psychological distress has been associated with poor treatment response 114 and 
prematurely abandoning treatment 115. It is likely that for successful treatment the 
multiple coexisting factors need to be addressed. Indeed, targeting PTSD 
symptoms may be a key factor in managing chronic pain patients with such 
symptomatology. Unfortunately, our study was not designed to evaluate 
treatment outcomes, although we acknowledge the need for well designed 
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longitudinal studies to answer questions such as whether management of PTSD 
would change treatment outcomes for chronic pain.  
The present study has limitations due its retrospective design. It is not 
possible to determine a causal relationship between chronic pain and PTSD. It is 
also not possible to determine causal relationships among chronic pain, PTSD 
and psychological distress as well as among chronic pain, PTSD and sleep 
disturbances. An additional limitation is that this survey was conducted with 
patients who sought treatment for their TMD problem in a tertiary care center 
which could overestimate the prevalence rate of PTSD and the relationships 
among PTSD, psychological distress and sleep disturbances found in the present 
study as compared to what occurs in the natural environment. Given that the 
patients in this study could represent a more skewed pain population compared 
to the typical patients seem at a general practice. On the other hand, we 
implemented strict inclusion criteria in each diagnostic group (MM and TMJ 
group) whereby only patients with primary and when given a secondary 
diagnosis of MM pain (MM group) or TMJ pain (TMJ group) were included in 
order to have a more accurate sample. These inclusion criteria probably 
strengthen our findings given that our sample would be more representative of a 
more precise MM pain and TMJ pain population and thus decreasing the 
likelihood for potential errors associated with differential diagnosis.  
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Chapter 7. Conclusion 
 
The present study replicates and extends previous investigations 
addressing the relationship between chronic pain and PTSD symptoms. 
Approximately 13% of patients reporting to an Orofacial Pain Clinic met criteria 
for PTSD symptomatology. A higher prevalence rate of PTSD symptoms was 
detected for patients in the MM group (14.9%) as compared to patients in the 
TMJ group (9.9%). This difference was not statistically significant; consequently, 
our primary hypothesis that the prevalence of PTSD symptoms would be higher 
for patients in the MM group than for patients in the TMJ group was not 
confirmed. There was, however, a trend suggesting a higher prevalence of PTSD 
symptomatology in the MM group when compared to the TMJ group. Analysis of 
our findings revealed that psychological distress measured on both SCL-90-R 
and MPI and sleep disturbances measured on the PSQI were linked to PTSD 
symptomatology in both MM and TMJ group. We also found that MM pain 
patients presented with more life interference, affective distress and sleep 
disturbances, and less life control than TMJ pain patients confirming and 
expanding previous studies addressing the differences between MM and TMJ 
pain patients. However, when the presence of PTSD was considered these 
differences were mostly maintained in the subgroups without PTSD 
symptomatology. Hence, the presence of PTSD appears to modulate not only the 
level of psychological distress in TMD patients and sleep disturbances, but also 
the differences between MM and TMJ groups. Further longitudinal research is 
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necessary to explore the relationship between chronic pain and PTSD patients 
and to devise effective multidimensional treatment.  
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